Wockhardt Ltd.

NSE: WOCKPHARMA  SECTOR: Pharmaceuticals & Drugs

434.1
+39.45 (10%)

Price Summary

Today's High

₹ 434.1

Today's Low

₹ 383.05

52 Week High

₹ 451.95

52 Week Low

₹ 147.2

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

4807.95932973 Cr.

Enterprise Value

6526.29932973 Cr.

No. of Shares

11.0756953 Cr.

P/E

0

P/B

2.8

Face Value

₹ 5

Div. Yield

0%

Book Value (TTM)

₹  155.0574

CASH

157.48 Cr.

DEBT

1875.82 Cr.

Promoter Holding

72.13%

EPS (TTM)

₹  -40.1257

Sales Growth

-36.2208423451708%

ROE

-21.4098128308808 %

ROCE

-3.95032256230994 %

Profit Growth

-16.8550633742215 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year-36.22%
3 Year-15.81%
5 Year-6.18%

Profit Growth (in Cr.)

1 Year-182.23%
3 Year-219.01%
5 Year-193.02%

ROE%

1 Year-21.41%
3 Year-7.49%
5 Year-1.98%

ROCE %

1 Year-3.95%
3 Year1.48%
5 Year3.32%

Debt/Equity

1.9445602031825

Price to Cash Flow

21.71

Interest Cover Ratio

-0.536630785302266

CFO/PAT (5 Yr. Avg.)

NA

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2020 72.13 37.12
Dec 2019 72.4 24.7
Sep 2019 74.04 3.96
Jun 2019 74.06 2.07
Mar 2019 74.07 1.52
* Figures given above are % of equity capital

 Strengths

  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 25.3338381116649.

 Limitations

  • The company has shown a poor profit growth of -219.008753959515% for the Past 3 years.
  • The company has shown a poor revenue growth of -15.805715065865% for the Past 3 years.
  • Company has a poor ROE of -7.48704541682565% over the past 3 years.
  • Company has a poor ROCE of 1.47991181169095% over the past 3 years
  • Company has low Interest coverage ratio of -0.536630785302266.
  • Company has high debtor days of 258.822271407943.
  • Promoter pledging is high as 37.12%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
Net Sales 424.28 328.74 162.21 177.58 294.96
Total Expenditure 340.29 339.98 253.36 273.13 307.27
Operating Profit 83.99 -11.24 -91.15 -95.55 -12.31
Other Income 13.76 19.77 43.44 9.74 14.96
Interest 54.27 51.55 58.05 58.61 46.97
Depreciation 42 43.84 44.48 46.08 42.97
Exceptional Items 0 0 0 -142.48 0
Profit Before Tax 1.48 -86.86 -150.24 -332.98 -87.29
Tax 1.41 -17.02 -51.98 -114.04 -29.91
Profit After Tax 0.07 -69.84 -98.26 -218.94 -57.38
Adjusted EPS (Rs) 0 -0.63 -0.89 -1.98 -0.52

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 2216.53 2297.52 2477.29 2149.95 1371.22
Total Expenditure 2090.61 2164.07 2154.4 2069.48 1401.8
Operating Profit 125.92 133.45 322.89 80.47 -30.58
Other Income 61.5 259.71 56.85 34.8 85.82
Interest 107.86 168.72 169.58 170.88 220.17
Depreciation 99.08 105.66 106.24 119.82 173.39
Exceptional Items 0 0 0 0 0
Profit Before Tax -19.52 118.78 103.92 -175.43 -338.32
Tax -27.86 -18.34 35.26 -93.54 -107.2
Net Profit 8.34 137.12 68.66 -81.89 -231.12
Adjusted EPS (Rs.) 0.75 12.4 6.21 -7.4 -20.87

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 55.25 55.27 55.32 55.34 55.37
Total Reserves 1112.71 1164.05 1239.37 1171.29 939.25
Borrowings 1432.84 1282.62 758.39 941.93 519.5
Other N/C liabilities 676.32 414.78 499.5 402.98 692.74
Current liabilities 1293.15 1594.02 1789.03 1827.74 2305.25
Total Liabilities 4570.27 4510.74 4341.61 4399.28 4512.11
Assets
Net Block 1401.8 1464.51 1422.73 1614.32 2044.35
Capital WIP 663.6 665.34 653.34 380.9 305.29
Investments 297.22 297.22 297.22 297.27 297.27
Loans & Advances 186.3 277.72 277.49 236.22 202.02
Other N/C Assets 0 9.18 23.71 40.63 56.63
Current Assets 2021.35 1796.77 1667.12 1829.94 1606.55
Total Assets 4570.27 4510.74 4341.61 4399.28 4512.11
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax -19.52 118.78 103.92 -175.43 -338.32
Adjustment 165.63 35.72 251.33 273.57 355.96
Working Capital Changes -505.34 -364.51 -225.82 -15.4 204.37
Tax Paid -3.95 -25.01 -10.05 -24.41 -0.5
Operating Cash Flow -363.18 -235.02 119.38 58.33 221.51
Investing Cash Flow -1014.95 368.91 450.74 120.33 -16.15
Financing Cash Flow 763.89 -133.06 -523.84 -69.42 -273.97
Net Cash Flow -614.24 0.83 46.28 109.24 -68.61

Corporate Actions

Company Presentations

Company News

Wockhardt Stock Price Analysis and Quick Research Report. Is Wockhardt an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Wockhardt and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 221.51 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Wockhardt has a Debt to Equity ratio of 1.9445602031825 , which is a weak indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Wockhardt , the EPS growth was -182.079526409688 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Wockhardt has OPM of -2.23013083239742 % which is a bad sign for profitability.
     
  • ROE: Wockhardt have a poor ROE of -21.4098128308808 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Wockhardt

X